Table 1.
Protein | Treatment group | |||
---|---|---|---|---|
Sal-Veh | Sal-MTEP | Coc-Veh | Coc-MTEP | |
CAMK II | 0.724 ± 0.093 | 0.883 ± 0.058 | 0.840 ± 0.095 | 0.723 ± 0.067 |
Dynamin II/III | 0.815 ± 0.095 | 0.830 ± 0.101 | 0.918 ± 0.068 | 0.780 ± 0.071 |
GRK2 | 0.553 ± 0.046 | 0.460 ± 0.068 | 0.629 ± 0.068∗ | 0.702 ± 0.058∗ |
Homer 1b/c | 0.404 ± 0.044 | 0.413 ± 0.050 | 0.450 ± 0.051 | 0.374 ± 0.041 |
Homer 2a/b | 1.347 ± 0.141 | 1.500 ± 0.117 | 1.562 ± 0.184 | 1.372 ± 0.144 |
All data were normalized to calnexin control (within sample) and to the Sal-Veh control (between groups). Data represent mean immunoreactivity ± SEM (n = 5–9). ∗ p < 0.05 compared to Sal.